Recent developments at Medical Marijuana, Inc. prompted the investor news organization to highlight MJNA’s stock for the second time in less than three weeks.<\/span><\/i><\/p>\n
A review of Medical Marijuana, Inc.\u2019s stock was published on <\/span>Insider Financial<\/span><\/i> for the second time in three weeks. Spotlighting what it describes as a recent \u201cuptick in prices,\u201d the investing news organization doubled down on its claim of a continued upward trend in share price.<\/span><\/p>\n
Insider Financial<\/span><\/i> provides insights and news for knowledgeable investors looking for guidance on how best to execute possible public and private capital allocation decisions.<\/span><\/p>\n
After first pointing out the rise in MJNA\u2019s market valuation from just above $180 million to around $305 million, the article then spotlights several of MJNA\u2019s recent announcements.<\/span><\/p>\n
Among the announcements highlighted in the article was the news out of Brazil, in which a<\/span> Federal judge there ordered the government to subsidize payments<\/span><\/a> for (Real Scientific Hemp Oil<\/span>\u2122<\/span> (RSHO<\/span>\u2122<\/span>)<\/span> CBD<\/span><\/a> hemp oil for a Brazilian citizen.<\/span><\/p>\n
The article also spotlights<\/span> MJNA\u2019s new Subscribe & Save program<\/span><\/a>, which allows customers to receive automatic monthly shipments of their favorite CBD products at a 20% discount.<\/span><\/p>\n
Altogether, the developments prompted the news organization up the ante on its <\/span>previous bullish advice<\/span><\/a> on MJNA and to conclude that MJNA is \u201cpoised for success.\u201d<\/span><\/p>\n
You can read the full <\/span>Insider Financial<\/span><\/i> article<\/span> HERE<\/span><\/a>.<\/span><\/p>\n
Learn more about<\/span> Medical Marijuana, Inc.<\/span><\/a> and its portfolio of companies on our<\/span> news feed<\/span><\/a>.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"